Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient

被引:25
作者
Lones, MA
Kirov, I
Said, JW
Shintaku, IP
Neudorf, S
机构
[1] St Joseph Hosp, Dept Pathol, Childrens Hosp Orange Cty, Orange, CA 92863 USA
[2] Childrens Hosp Orange Cty, Div Oncol, Orange, CA 92668 USA
[3] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA
[4] Childrens Hosp Orange Cty, Div Hematopoiet Stem Cell Transplantat, Orange, CA 92668 USA
关键词
hematopoietic stem cell transplantation; autologous transplantation; lymphoproliferative disorders; herpesvirus; child;
D O I
10.1038/sj.bmt.1702593
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Post-transplant lymphoproliferative disorder (PTLD) is a complication of allogeneic bone marrow transplantation (BMT). Rare cases of PTLD after autologous BMT have been reported only in adults. This case report is the first to describe PTLD in a pediatric patient after autologous peripheral stem cell transplantation (PSCT), This 2-year-old male with stage IV neuroblastoma underwent autologous PSCT, The post-PSCT course was complicated by fever with hematochezia and a lung mass. On day 94 post PSCT, colonoscopy revealed an ulcer due to a PTLD, monomorphic type, B cell phenotype, associated with Epstein-Barr virus. Fine needle aspiration identified the lung mass as neuroblastoma, PTLD can occur in pediatric autologous PSCT recipients, and may occur more frequently in autologous grafts manipulated by T cell depletion or CD34(+) cell selection.
引用
收藏
页码:1021 / 1024
页数:4
相关论文
共 17 条
[1]  
ANDERSON KC, 1990, BLOOD, V76, P235
[2]   Epstein-Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukaemia [J].
Briz, M ;
Fores, R ;
Regidor, C ;
Busto, MJ ;
Cajal, SRY ;
Cabrera, R ;
Diez, JL ;
Sanjuan, I ;
Fernandez, MN .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) :485-487
[3]  
CHAO NJ, 1993, TRANSPLANTATION, V55, P1425
[4]   Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation [J].
Cook, RC ;
Connors, JM ;
Gascoyne, RD ;
Fradet, G ;
Levy, RD .
LANCET, 1999, 354 (9191) :1698-1699
[5]   Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders [J].
Faye, A ;
Van Den Abeele, T ;
Peuchmaur, M ;
MAthieu-Boue, A ;
Vilmer, E .
LANCET, 1998, 352 (9136) :1285-1285
[6]   ANTI-B-CELL MONOCLONAL-ANTIBODIES IN THE TREATMENT OF SEVERE B-CELL LYMPHOPROLIFERATIVE SYNDROME FOLLOWING BONE-MARROW AND ORGAN-TRANSPLANTATION [J].
FISCHER, A ;
BLANCHE, S ;
LEBIDOIS, J ;
BORDIGONI, P ;
GARNIER, JL ;
NIAUDET, P ;
MORINET, F ;
LEDEIST, F ;
FISCHER, AM ;
GRISCELLI, C ;
HIRN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21) :1451-1456
[7]  
Harris NL, 1997, SEMIN DIAGN PATHOL, V14, P8
[8]   Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases [J].
Hauke, RJ ;
Greiner, TC ;
Smir, BN ;
Vose, JM ;
Tarantolo, SR ;
Bashir, RM ;
Bierman, PJ .
BONE MARROW TRANSPLANTATION, 1998, 21 (12) :1271-1274
[9]   Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation [J].
Holmberg, LA ;
Boeckh, M ;
Hooper, H ;
Leisenring, W ;
Rowley, S ;
Heimfeld, S ;
Press, O ;
Maloney, DG ;
McSweeney, P ;
Corey, L ;
Maziarz, RT ;
Appelbaum, FR ;
Bensinger, W .
BLOOD, 1999, 94 (12) :4029-4035
[10]  
Lones MA, 1998, ARCH PATHOL LAB MED, V122, P708